CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine

Qin Li,1,* Jie Ren,2,* Wei Liu,3 Guoqin Jiang,2 Rongkuan Hu1 1GenePharma Co., Ltd., Suzhou, 215125, Jiangsu, People’s Republic of China; 2Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215004, People’s Republic of China; 3Departm...

Full description

Bibliographic Details
Main Authors: Li Q, Ren J, Liu W, Jiang G, Hu R
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:Drug Design, Development and Therapy
Subjects:
cpg
ifn-γ
tlr9
mrna vaccine
neoantigen
Online Access:https://www.dovepress.com/cpg-oligodeoxynucleotide-developed-to-activate-primate-immune-response-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/cpg-oligodeoxynucleotide-developed-to-activate-primate-immune-response-peer-reviewed-fulltext-article-DDDT

Similar Items